Skip to main content
padlock icon - secure page this page is secure

Recent Patents on Proteases and Kinases as Anti-Infective Agents: A Review

Buy Article:

$68.00 + tax (Refund Policy)

Infectious diseases have haunted human populations for millennia. Still we are struggling with this scourge because of multiple complexities. These include the emergence of new pathogenic species due to mutations owing to the naturally ticking evolutionary clock. In addition, under the selective pressure of existing powerful antibiotics, which have been helpful in effectively managing many infectious diseases for a long time, resistant species arise quite commonly. Therefore, there is always an urgent need to invent new strategies to fight new strains of these pathogens. We review here some important patents that have been licensed for drug development pertaining to protease and kinase inhibitors. Instead of being comprehensive, we have been selective in our choices. We apologize to those whose patents we could not cite. Our goal is to inform public at large of the new inventions in the pipeline and their status toward development of these technologies as drugs in the clinic.

No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Patents; Raf kinase inhibitors; anti-infective agents; pharmaceutical industry; protease inhibitors; tyrosine kinase inhibitors

Document Type: Research Article

Affiliations: 455 Whitehead Biomedical Research Building, Emory University School of Medicine; 615 Michael Street, Atlanta, GA 30322 USA.

Publication date: June 1, 2006

More about this publication?
  • Recent Patents on Anti-Infective Drug Discovery publishes review articles on recent patents in the field of anti-infective drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-infective drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-infective drug design and discovery.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more